

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
| Drug interactions | D004347 | — | — | 1 | — | — | — | — | 1 |
| Infections | D007239 | EFO_0000544 | — | 1 | — | — | — | — | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | — | — | — | 1 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | — | — | — | — | 1 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | — | — | — | — | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | — | — | — | — | 1 |
| Drug common name | Tarenflurbil |
| INN | tarenflurbil |
| Description | (R)-flurbiprofen is a flurbiprofen. It is an enantiomer of a (S)-flurbiprofen. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1 |
| PDB | — |
| CAS-ID | 51543-40-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL190083 |
| ChEBI ID | 38666 |
| PubChem CID | 92337 |
| DrugBank | — |
| UNII ID | 501W00OOWA (ChemIDplus, GSRS) |
